Your SlideShare is downloading. ×
0
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Opportunistic Mycoses
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Opportunistic Mycoses

5,980

Published on

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
5,980
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
245
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Opportunistic Mycoses
    • Infections due to fungi of low virulence in patients who are immunologically compromised
    www.freelivedoctor.com
  • 2. Medical Mycology Iceberg www.freelivedoctor.com
  • 3. PATHOGENIC FUNGI
    • NORMAL HOST
      • Systemic pathogens - 25 species
      • Cutaneous pathogens - 33 species
      • Subcutaneous pathogens - 10 species
    • IMMUNOCOMPROMISED HOST
        • Opportunistic fungi - 300 species
    www.freelivedoctor.com
  • 4. HOST-PATHOGEN EQUILIBRIUM
    • NUMBER OF ORGANISMS X VIRULENCE = DISEASE HOST RESISTANCE
    www.freelivedoctor.com
  • 5. Opportunistic Fungi
    • 1. Saprophytic - from the environment
    • 2. Endogenous – a commensal organism
    www.freelivedoctor.com
  • 6. Opportunistic Fungi
    • Include many species from:
    • A (Aspergillus)
    • To
    • Z (Zygomyces)
    www.freelivedoctor.com
  • 7. MOST SERIOUS OPPORTUNISTIC INFECTIONS
    • CANDIDA SPECIES
    • ASPERGILLUS SPECIES
    • MUCOR SPECIES (ZYGOMYCES)
    www.freelivedoctor.com
  • 8. Upward Trend In Opportunistic Mycoses
    • Increased clinical awareness
    • Improved clinical diagnostic tools
    • Improved laboratory diagnostic technics
    • An increase in susceptible hosts.
    • More invasive diagnostic and therapeutic procedures
    www.freelivedoctor.com
  • 9. Must distinguish between
    • Transient fungemia
    • Colonization
    • Infection
    www.freelivedoctor.com
  • 10. Transient fungemia
    • The fortuitous isolation of a commensal or environmental organism
    www.freelivedoctor.com
  • 11. COLONIZATION EYE SKIN UROGENITAL TRACT ANUS MOUTH RESPIRATORY TRACT Multiplication of an organism at a given site without harm to the host www.freelivedoctor.com
  • 12. INFECTION EYE SKIN UROGENITAL TRACT ANUS MOUTH RESPIRATORY TRACT Invasion and multiplication of organisms in body tissue resulting in local cellular injury . www.freelivedoctor.com
  • 13. Predisposing Factors
    • Malignancies
    • Leukemias
    • Lymphomas
    • Hodgkins Disease
    www.freelivedoctor.com
  • 14. Predisposing Factors
    • Drug therapies
    • Anti-neoplastics
    • Steroids
    • Immunosuppressive drugs
    www.freelivedoctor.com
  • 15. Predisposing Factors
    • Antibiotics
    • Over-use or inappropriate use of antibiotics alter the normal flora allowing fungal overgrowth
    www.freelivedoctor.com
  • 16. Predisposing Factors
    • Therapeutic procedures
    • Solid organ or bone marrow transplant
    • Open heart surgery
    • Indwelling catheters
    • Artificial heart valves
    • Radiation therapy
    www.freelivedoctor.com
  • 17. Predisposing Factors
    • Other Factors
    • Severe burns
    • Diabetes
    • Tuberculosis
    • IV Drug use
    www.freelivedoctor.com
  • 18. Predisposing Factors
    • AIDS
    www.freelivedoctor.com
  • 19. Human Immunodeficiency Virus (HIV) HIV destroys the CD4 helper T cells www.freelivedoctor.com
  • 20. CD4 helper T cells are the basis of cell mediated immunity and play a role in host defenses against fungal diseases ERGO www.freelivedoctor.com
  • 21.
    • Virtually all AIDS patients will have a fungal infection sometime during the course of their illness
    www.freelivedoctor.com
  • 22. BIOFILMS
    • A POLYSACCHARIDE SLIME WHICH IS A MICROCOLONY OF ORGANISMS CONTAINING CHANNELS TO BRING IN NUTRIENTS AND CARRY OFF WASTE
    www.freelivedoctor.com
  • 23. Diagnosis of opportunistic infections requires a high index of suspicion
    • Atypical signs or symptoms
    • Unusual organ affinity
    • Outside the endemic area
    • Unusual Histopathology
    • Etiologic agent may be a saprophyte
    www.freelivedoctor.com
  • 24. CLINICAL PRESENTATION
    • Atypical Signs and Symptoms
    • Unusual Organ Affinity
    • Outside Endemic Area
    • Unusual histopathology
    • Unusual Pathogens
    www.freelivedoctor.com
  • 25. NORMAL PATIENT
    • Malasezzia furfur
    • Tinea versicolor
    • (mild disease)
    www.freelivedoctor.com
  • 26. www.freelivedoctor.com
  • 27. www.freelivedoctor.com
  • 28. COMPROMISED PATIENTS
    • Malasezzia furfur can cause disseminated infection--------Particularly in patients receiving hyperalimentation.
    www.freelivedoctor.com
  • 29. COMPROMISED IMMUNE SYSTEM Malasezzia furfur NUMBER OF ORGANISMS x LOW VIRULENCE = DISEASE HOST RESISTANCE www.freelivedoctor.com
  • 30. www.freelivedoctor.com
  • 31. CLINICAL PRESENTATION
    • Atypical Signs and Symptoms
    • Unusual Organ Affinity
    • Outside Endemic Area
    • Unusual histopathology
    • Unusual Pathogens
    www.freelivedoctor.com
  • 32. Candida species Endogenous www.freelivedoctor.com
  • 33. Normal Flora
    • The population of microorganisms that may be found residing in or on the human body without causing disease.
    www.freelivedoctor.com
  • 34. COMPETENT IMMUNE SYSTEM Candida albicans NUMBER OF ORGANISMS x VIRULENCE = NO DISEASE HOST RESISTANCE www.freelivedoctor.com
  • 35. COMPROMISED IMMUNE SYSTEM Candida albicans NUMBER OF ORGANISMS = DISEASE HOST RESISTANCE www.freelivedoctor.com
  • 36. www.freelivedoctor.com
  • 37. www.freelivedoctor.com
  • 38. IMMUNOCOMPROMISED PATIENTS CAN DEVELOP HEPATIC CANDIDIASIS www.freelivedoctor.com
  • 39. www.freelivedoctor.com
  • 40. Candida species
    • In the previous lecture I only mentioned Candida albicans . There are several Candida species that infect the compromised host.
    www.freelivedoctor.com
  • 41. Candida species
    • C. glabrata
    • C. krusei
    • C. torulopsis
    • C. parapsilosis
    • C. lusitaniae
    • C. dubliniensis
    www.freelivedoctor.com
  • 42. Cryptococcosis
    • A sub-acute or chronic infection which may affect the lungs or skin but most commonly manifests as a meningitis
    www.freelivedoctor.com
  • 43. Ecological Niche Cryptococcus neoformans
    • pigeon droppings
    • Chicken droppings
    www.freelivedoctor.com
  • 44. Cryptococcus neoformans PORTAL OF ENTRY
    • INHALATION
    • INOCULATION
    www.freelivedoctor.com
  • 45. www.freelivedoctor.com
  • 46. www.freelivedoctor.com
  • 47. www.freelivedoctor.com
  • 48. www.freelivedoctor.com
  • 49. www.freelivedoctor.com
  • 50. www.freelivedoctor.com
  • 51. www.freelivedoctor.com
  • 52. Cryptococcus neoformans LOW NUMBER X HIGH VIRULENCE = NO DISEASE NORMAL HOST www.freelivedoctor.com
  • 53. Cryptococcus neoformans LOW NUMBER X HIGH VIRULENCE = INFECTION COMPROMISED HOST www.freelivedoctor.com
  • 54. Cryptococcosis
    • In the Compromised patient:
    • Amphotericin B
    • 5 FC
    • Then Fluconazole the remainder of their life.
    • Fluconazole penetrates the CSF
    www.freelivedoctor.com
  • 55. www.freelivedoctor.com
  • 56. www.freelivedoctor.com
  • 57. SPOROTRICHOSIS Primarily a disease of the cutaneous tissue and lymph nodes. Recently, pulmonary disease. www.freelivedoctor.com
  • 58. PORTALS OF ENTRY
    • Inhalation
    • Inoculation
    www.freelivedoctor.com
  • 59. www.freelivedoctor.com
  • 60. ECOLOGICAL ASSOCIATIONS
    • Rose thorns
    • Sphagnum moss
    • Timbers
    • Soil
    www.freelivedoctor.com
  • 61. SPOROTRICHOSIS www.freelivedoctor.com
  • 62. www.freelivedoctor.com
  • 63. Blastomycosis in AIDS patients
    • One report
    • 16 Patients
    • 10 localized disease
      • 7-lung, 2-skin, 1 CNS
    • 6 Disseminated
      • 5/6 – CNS
    • All did poorly
    www.freelivedoctor.com
  • 64. Aspergillus species HIGH NUMBER X LOW VIRULENCE = NO DISEASE NORMAL HOST www.freelivedoctor.com
  • 65. Aspergillus species LOW NUMBER X LOW VIRULENCE = INFECTION COMPROMISED HOST www.freelivedoctor.com
  • 66. www.freelivedoctor.com
  • 67. www.freelivedoctor.com
  • 68. CLINICAL PRESENTATION
    • Atypical Signs and Symptoms
    • Unusual Organ Affinity
    • Outside Endemic Area
    • Unusual histopathology
    • Unusual Pathogens
    www.freelivedoctor.com
  • 69. AIDS Patient
    • Pneumocystis pneumonia
    • Disseminated coccidioidomycosis
    • (not pulmonary)
    • Mycelial forms in abscesses
    • (not spherules)
    • Outside the endemic area
    • (St. Louis, MO)
    www.freelivedoctor.com
  • 70. Spherules www.freelivedoctor.com
  • 71. www.freelivedoctor.com
  • 72. HISTOPLASMOSIS IN AIDS PATIENTS
    • ALL CASES ARE DISSEMINATED
    • RELAPSES ARE GREATER THAN 50 %
    • RAPIDLY FATAL IN 10 %
    www.freelivedoctor.com
  • 73. AIDS Patients
    • Disseminated histoplasmosis
    • (not pulmonary disease)
    • New York City
    • (outside the endemic region)
    www.freelivedoctor.com
  • 74. www.freelivedoctor.com
  • 75. www.freelivedoctor.com
  • 76. www.freelivedoctor.com
  • 77. CLINICAL PRESENTATION
    • Atypical Signs and Symptoms
    • Unusual Organ Affinity
    • Outside Endemic Area
    • Unusual Histopathology
    • Unusual Pathogens
    www.freelivedoctor.com
  • 78. INFLAMMATORY REACTION
    • NORMAL HOST
      • PYOGENIC
      • GRANULOMATOUS
    • IMMUNODEFICIENT HOST
      • NECROTIC
    www.freelivedoctor.com
  • 79. CLINICAL PRESENTATION
    • Atypical Signs and Symptoms
    • Unusual Organ Affinity
    • Outside Endemic Area
    • Unusual histopathology
    • Unusual Pathogens
    www.freelivedoctor.com
  • 80. Opportunistic Fungi
    • Include many species from:
    • A (Aspergillus)
    • To
    • Z (Zygomyces)
    www.freelivedoctor.com
  • 81. Penicillium marneffei
    • Usually not a pathogen
    • The only dimorphic penicillium
    • Produces a red pigment
    • Endemic in the Far East
    www.freelivedoctor.com
  • 82. www.freelivedoctor.com
  • 83. www.freelivedoctor.com
  • 84. www.freelivedoctor.com
  • 85. www.freelivedoctor.com
  • 86. Pneumocystis jiroveci Recently confirmed as a member of Kingdom Fungi. Formerly thought to be a protozoan. www.freelivedoctor.com
  • 87. www.freelivedoctor.com
  • 88. Cryptococcus neoformans
    • Diabetes mellitus
    • Tuberculosis
    • Lymphoma
    • Hodgkin’s disease
    • Corticosteroid therapy
    • Immunosuppression
    www.freelivedoctor.com
  • 89. Candida albicans
    • Prolonged antibiotic therapy
    • Prolonged intravenous therapy
    • Prolonged urinary catheters
    • Corticosteroid therapy
    • Diabetes mellitus
    • Hyperalimentation
    • Immunosuppression
    www.freelivedoctor.com
  • 90. Torulopsis (Candida) glabrata
    • Cytotoxic drugs
    • Immunosuppression
    • Diabetes mellitus
    • Hyperalimentation
    • Intravenous catheters
    www.freelivedoctor.com
  • 91. www.freelivedoctor.com
  • 92. Mucormycetes
    • Diabetes mellitus
    • Leukemias
    • Corticosteroid therapy
    • Intravenous therapy
    • Severe burns
    www.freelivedoctor.com
  • 93. Aspergillus species
    • Leukemias
    • Corticosteroid therapy
    • Tuberculosis
    • Immunosuppression
    • Intravenous drug abuse
    www.freelivedoctor.com
  • 94. IMPROVING TREATMENT
    • New Drugs
    • New therapeutic regimen
    • Aggressive therapy
    • Conjunctive therapy
    www.freelivedoctor.com
  • 95. IMPROVING TREATMENT
    • New Drugs
    • Lipid Amphotericin B
    • Third generation azoles
    • (Posaconazole, Voriconazole)
    • New classes of antifungal agents
    • (Echinocandins)
    www.freelivedoctor.com
  • 96. IMPROVING TREATMENT
    • New Therapeutic Regimen
    • Combination Therapy
    • Simultaneously administering two drugs
    • Sequential Tx with two or more drugs
    • Alternate Administration of two or more
    www.freelivedoctor.com
  • 97. IMPROVING TREATMENT
    • AGGRESSIVE THERAPY
    • FOR IMMUNOCOMPROMISED PATIENTS
    • Prophylactic – Anti-fungal agents at, or near, the time of chemotherapy.
    • Posaconazole now approved.
    www.freelivedoctor.com
  • 98. IMPROVING TREATMENT
    • AGGRESSIVE THERAPY
    • FOR IMMUNOCOMPROMISED PATIENTS
    • 2. Empirical – Start therapy when patient at risk, i.e., fever and/or infiltrate without response to anti-bacterials.
    www.freelivedoctor.com
  • 99. IMPROVING TREATMENT
    • AGGRESSIVE THERAPY
    • FOR IMMUNOCOMPROMISED PATIENTS
    • 3. Pre-emptive – When there is some additional evidence of fungal infection (serology, isolate, etc.)
    www.freelivedoctor.com
  • 100. IMPROVING TREATMENT
    • CONJUNJUNCTIVE THERAPY
    • Antifungal agent plus a recombinant monoclonal antibody.
    www.freelivedoctor.com
  • 101. IMPROVING TREATMENT
    • CONJUNJUNCTIVE THERAPY
    • FOR IMMUNOCOMPROMISED PATIENTS
    • The use of anti-fungal agents with immunotherapy.
    www.freelivedoctor.com
  • 102. Immunotherapy
    • Interferons
    • Colony stimulating factors
    • Interleukins
    www.freelivedoctor.com

×